Lysyl	NN
oxidases	NNS
regulate	VBP
fibrillar	NN
collagen	NN
remodelling	NN
in	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
progressive	JJ
scarring	NN
disease	NN
of	IN
the	DT
lung	NN
with	IN
few	JJ
effective	JJ
therapeutic	JJ
options	NNS
.	.

Structural	JJ
remodelling	NN
of	IN
the	DT
extracellular	JJ
matrix	NN
[	(
i.e.	FW
collagen	NN
cross-linking	JJ
mediated	VBN
by	IN
the	DT
lysyl-oxidase	NN
(	(
LO	NN
)	)
family	NN
of	IN
enzymes	NNS
(	(
LOX	NN
,	,
LOXL1-4	NN
)	)
]	)
might	MD
contribute	VB
to	TO
disease	NN
pathogenesis	NN
and	CC
represent	VBP
a	DT
therapeutic	JJ
target	NN
.	.

This	DT
study	NN
aimed	VBN
to	TO
further	RB
our	PRP$
understanding	NN
of	IN
the	DT
mechanisms	NNS
by	IN
which	WDT
LO	NNP
inhibitors	NNS
might	MD
improve	VB
lung	NN
fibrosis	NN
.	.

Lung	NN
tissues	NNS
from	IN
IPF	NN
and	CC
non-IPF	JJ
subjects	NNS
were	VBD
examined	VBN
for	IN
collagen	NN
structure	NN
(	(
second	JJ
harmonic	JJ
generation	NN
imaging	NN
)	)
and	CC
LO	NN
gene	NN
(	(
microarray	NN
analysis	NN
)	)
and	CC
protein	NN
(	(
immunohistochemistry	NN
and	CC
western	NN
blotting	NN
)	)
levels	NNS
.	.

Functional	JJ
effects	NNS
(	(
collagen	NN
structure	NN
and	CC
tissue	NN
stiffness	NN
using	VBG
atomic	JJ
force	NN
microscopy	NN
)	)
of	IN
LO	NN
inhibitors	NNS
on	IN
collagen	NN
remodelling	NN
were	VBD
examined	VBN
in	IN
two	CD
models	NNS
,	,
collagen	NN
hydrogels	NNS
and	CC
decellularized	VBN
human	JJ
lung	NN
matrices	NNS
.	.

LOXL1/LOXL2	NN
gene	NN
expression	NN
and	CC
protein	NN
levels	NNS
were	VBD
increased	VBN
in	IN
IPF	NN
versus	CC
non-IPF	JJ
.	.

Increased	VBN
collagen	NN
fibril	NN
thickness	NN
in	IN
IPF	NN
versus	CC
non-IPF	JJ
lung	NN
tissues	NNS
correlated	VBD
with	IN
increased	VBN
LOXL1/LOXL2	NN
,	,
and	CC
decreased	VBD
LOX	NNP
,	,
protein	NN
expression	NN
.	.

b-Aminoproprionitrile	NN
(	(
b-APN	NN
;	:
pan-LO	JJ
inhibitor	NN
)	)
but	CC
not	RB
Compound	NN
A	NN
(	(
LOXL2-specific	JJ
inhibitor	NN
)	)
interfered	VBD
with	IN
transforming-growth-factor-b-induced	JJ
collagen	NN
remodelling	NN
in	IN
both	CC
models	NNS
.	.

The	DT
b-APN	NN
treatment	NN
group	NN
was	VBD
tested	VBN
further	RB
,	,
and	CC
b-APN	NN
was	VBD
found	VBN
to	TO
interfere	VB
with	IN
stiffening	VBG
in	IN
the	DT
decellularized	VBN
matrix	NN
model	NN
.	.

LOXL1	NN
activity	NN
might	MD
drive	VB
collagen	NN
remodelling	NN
in	IN
IPF	NN
lungs	NNS
.	.

The	DT
interrelationship	NN
between	IN
collagen	NN
structural	JJ
remodelling	NN
and	CC
LOs	NNS
is	VBZ
disrupted	VBN
in	IN
IPF	NN
lungs	NNS
.	.

Inhibition	NN
of	IN
LO	NN
activity	NN
alleviates	VBZ
fibrosis	NN
by	IN
limiting	VBG
fibrillar	JJ
collagen	NN
cross-linking	NN
,	,
thereby	RB
potentially	RB
impeding	VBG
the	DT
formation	NN
of	IN
a	DT
pathological	JJ
microenvironment	NN
in	IN
IPF	NN
.	.

